I-Alli / Xenical / Orlistat, Ukulahlekelwa Isisindo, Ne-Thyroid Yakho

I-Alli yigama lesigqila samandla anciphise ngaphezu kwe-counter-version yegama lomuthi wegama lomuthi we-Xenical (owaziwa ngokujwayelekile njenge-orlistat).

I-Orlistat yenzelwe abantu abaneminyaka engu-18 ubudala noma ngaphezulu abangaphezu komzimba, futhi bane-BMI (index mass body) engama-30 noma ngaphezulu (obakhulu kakhulu), noma i-27-29 (ngokweqile) futhi inezinye izici zezempilo eziphezulu.

I-Orlistat isebenza ngokuvimbela i-enzyme egaxa amafutha emathunjini akho.

Isidakamizwa sisebenza kuphela emathunjini akho futhi senzelwe ukunciphisa amaphesenti angama-25 we-calories amafutha odlayo.

I-Orlistat iklanyelwe ukuthi isetshenziswe ngokuhlanganyela nomsebenzi owenziwe ngokomzimba kanye nekhalori ephansi / ukudla okuphansi kwamafutha. Amaphesenti angaphezu kuka-30 ama-kilojoule okuvela ekudleni ngakunye kufanele avele ngamafutha, lokhu kuzosiza ukunciphisa ukuvuvukala kwesisu kanye neminye imiphumela emibi. Ukudla okunamafutha amaningi kuhlanganiswe ne-orlistat kungabangela ukubola kwesisu nokuhuda okukhulu.

I-Orlistat ingaba yindlela ephumelelayo yokulahlekelwa isisindo kwabanye abantu. Umkhiqizi uthi uma usetshenziswa ngokuhambisana nekhalori encishisiwe / ukudla okunamafutha aphansi, abantu abadala bangalahlekelwa isisindo esingaphezu kwamaphesenti angu-50-ngokuyinhloko, kuzo zonke amapounds amabili olahlekelwayo, uzolahlekelwa i-orlistat ye-pounds yesithathu.

Ezinye izifundo, kodwa, zibonise ukuthi uma isebenza, imiphumela ye-orlistat ingamaphesenti angama-8 ukulahlekelwa kwesisindo ngaphezulu ngonyaka, uma kuqhathaniswa ne-placebo. Iningi labantu livame ukubuyisa isisindo ngonyaka emva kokuthatha lesi sidakamizwa.

Olunye ucwaningo lwathola ukuthi ukudla okuphansi kwe-carbohydrate kwakuphumelela nje njengokuhlanganiswa kwe-orlistat nokudla okunamafutha aphansi.

Ukuxhumana nokuxwayiswa

I-Orlistat ingaba nokuxhumana kweziguli ngezimo ezilandelayo. Uma unalezi zinkinga zempilo, udinga ukuxoxa ngokusetshenziswa kwe-orlistat nodokotela wakho, ngaphambi kokuqala:

AWAKHO ukuthatha i-orlistat uma:

Okuqhamuka uma udla imishanguzo

Enye yezingqinamba ezinkulu ze-orlistat yimiphumela emibi, engabandakanya:

Imiphumela emibi kakhulu futhi engozini ingasikisela ukulimala kwesibindi. Shayela udokotela wakho ngokushesha uma ubona noma iyiphi yalezi zimpawu ngenkathi uthatha i-orlistat:

Esikhathini esingavamile semiphumela emibi-engabandakanya ubunzima bokugwinya, ukuphefumula kanzima, ukucheka okungaqondakali / izikhala, noma ubuhlungu obukhulu besisu / esiswini-kufanele ubize u-911 noma ufune ukunakekelwa ngokushesha.

I-Orlistat ne-Your Thyroid

Ngonyaka ka-2009, i-FDA yamukele ukubuyekezwa kokubhalisa ukubhekwa kwe-levothyroxine amaphilisi e-sodium (ie, Synthroid, Levoxyl, njll) ukucebisa ukusebenzisana kwezidakamizwa ne-orlistat.

Ukwaziswa kuka-Levothyroxine kuhlanganisa isixwayiso esibonisa ukuthi ukusetshenziswa kwe-orlistat kunganciphisa ukukhishwa kwe-levothyroxine futhi kuholele hypothyroidism nokuthi odokotela bayelulekwa ukuba baphathe i-levothyroxine ne-orlistat okungenani amahora amane ngaphandle futhi benze ukuhlolwa okuvamile komsebenzi we -roid.

Ukwaziswa kwe-Xenical okuchazayo kuye kwabuyekezwa ukuze kuboniswe ukuxhumana okungenzeka phakathi kwe-orlistat ne-levothyroxine. Ngokuqondile:

Ngaphansi

Uma unesifo se-thyroid uzama ukunciphisa isisindo-njengabantu abaningi-bahlale bekhumbula ukuthi i-orlistat ingathinta imithi yakho ye-thyroid, futhi ikuenze ube ne-hypothyroid.

Thatha imithi yakho ye-thyroid okungenani amahora angu-4 ngaphandle kwe-Alli noma i-Xenical yakho. Futhi i-thyroid yakho ihlolwe kaningi ngenkathi uthatha imithi, ukuqinisekisa ukuthi akudingeki ukuthi ulungise umthamo wemithi yakho ye-thyroid ukuze ulandele ukungena.